Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer

Por Arango, Natalia Paez, Yuca, Erkan, Zhao, Ming, Evans, Kurt W., Scott, Stephen, Kim, Charissa, Gonzalez-Angulo, Ana Maria, Janku, Filip, Ueno, Naoto T., Tripathy, Debu, Akcakanat, Argun, Naing, Aung, Meric-Bernstam, Funda
Publicado no Breast Cancer Res (2017)

A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory

Por Arango, Natalia Paez, Brusco, Lauren, Shaw, Kenna R. Mills, Chen, Ken, Eterovic, Agda Karina, Holla, Vijaykumar, Johnson, Amber, Litzenburger, Beate, Khotskaya, Yekaterina B., Sanchez, Nora, Bailey, Ann, Zheng, Xiaofeng, Horombe, Chacha, Kopetz, Scott, Farhangfar, Carol J., Routbort, Mark, Broaddus, Russell, Bernstam, Elmer V., Mendelsohn, John, Mills, Gordon B., Meric-Bernstam, Funda
Publicado no Oncotarget (2017)